APRIL CHIN: Open Payments
NPI 1326824731 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,386 in 44 payments from 24 companies in 2025. Trend: 2023 $0 · 2024 $659 · 2025 $1,386
Food & beverage: $1,112Education: $274
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $216 |
| AstraZeneca Pharmaceuticals LP | 8 | $138 |
| Incyte Corporation | 3 | $134 |
| Stemline Therapeutics Inc. | 1 | $123 |
| Janssen Biotech, Inc. | 5 | $113 |
| Astellas Pharma US Inc | 2 | $109 |
| SEAGEN INC. | 1 | $79 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Adaptive Biotechnologies Corporation | 2 | $49 |
Products named: ELZONRIS, OPDIVO, REBLOZYL, ENHERTU, RYBREVANT, IMFINZI, KEYTRUDA, clonoSEQ.
Industry payments across FL — which companies pay providers there.
